The State Food and drug administration has approved two kinds of Chinese patent medicines from Kangyuan and Zhengda Tianqing in Jiangsu Province as the protected varieties of traditional Chinese Medicine

According to the regulations on the protection of traditional Chinese medicine varieties, the State Drug Administration approved jiuweixifeng granules produced by Jiangsu Kangyuan Pharmaceutical Co., Ltd and Guibai Huayu capsule produced by Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd as the first two-level protection varieties of traditional Chinese medicine, with the numbers of zyb2072018007 and zyb2072018008 respectively, with the protection period of seven years from the date of announcement It is hereby announced On October 29, 2018, State Food and Drug Administration of the people's Republic of China (SFDA) jiuweixifeng granules commodity name: Kangyuan ingredients: Gastrodia elata, Rehmannia officinalis, gentian, tortoise shell, uncaria, keel, ossified silkworm, bluestone, faban Pinellia Properties: the product is dark brown granules, sweet and slightly bitter Function indications: Ziyin calms the liver, calms the wind and dissipates phlegm It is used in children with mild to moderate Multiple Tic syndrome, which belongs to kidney yin deficiency and liver wind internal movement syndrome The symptoms include involuntary twitch of head and neck, five senses and limbs, abnormal voice in throat, little red tongue and moss, and fine stringed pulse Specification: 6G * 6 bags / box usage and dosage: boiled water, 4-6 years old, 1 bag at a time, twice a day; 7-9 years old, 1.5 bag at a time, twice a day; 10-14 years old, 2 bags at a time, twice a day The course of treatment was six weeks Adverse reactions: dizziness and drowsiness, transient dizziness and so on occurred in some patients after medication Contraindications: there is no clear notice: 1 There is no evidence for the use of this product in the treatment of severe and refractory tic disorder and tic hyperactivity disorder 2 The clinical trial of this product only supports the safety of use for 4 weeks, which should not be more than 4 weeks 3 There is no evidence of safety and efficacy of this product for children under 4 years old 4 The relationship between mild proteinuria and drugs is still uncertain 5 This product is a tablet, no swallowing tablets and experience of children with caution 6 Use with caution if you have a cold, fever or diarrhea 7 Use with caution if you are allergic Pharmacology and toxicology: the results of non Clinical Pharmacodynamics test showed that: This product can inhibit the writhing reaction of mice induced by acetic acid, inhibit the spontaneous activity of mice (reduce the number of spontaneous activities), prolong the sleep time of mice with threshold dose of pentobarbital sodium, shorten the maze time of mice, prolong the latent period of convulsion of mice induced by strychnine, improve the gait of rats induced by IDPN, and reduce The number of involuntary rotations in the twitch model rats and the open field analysis showed that it could improve the behavior of IDPN model and reduce the Da content in the striatum of amphetamine model mice (source: instruction manual of smart drugs) in addition, according to the database of smart drugs assistance and key monitoring drugs, the drug was included in the catalogue of basic medical insurance, work-related injury insurance and maternity insurance drugs (2017 version) issued by the Department of human resources and social security of Henan Province on December 27, 2017 Guibai Huayu capsule trade name: qingbishu general name: Guibai Huayu capsule ingredients: Angelica, phellodendron, white peony, vinegar yanhusuo, licorice Function indications: promoting blood circulation and removing blood stasis, clearing away dampness and heat It is used for chronic abacterial prostatitis with blood stasis and damp heat syndrome The symptoms are frequent urination, urgency of urination, painful urination There is often a small amount of mucus at the urethra mouth, suffering from mouth pain and short yellow urine In addition, according to the pharmaceutical intelligence bid winning information query database, the drug has won the bid in 9 regions including Hainan, Jiangxi, Hubei and Hunan At present, the latest bid price is 118 yuan (0.3g * 24 tablets) Information source: data source of the State Drug Administration: Pharmaceutical intelligence database